National Drug Dependence Treatment Centre, Department of Psychiatry, 4th Floor, Teaching Block, All India Institute of Medical Sciences, New Delhi 110029, India.
Bull World Health Organ. 2021 Jun 1;99(6):422-428. doi: 10.2471/BLT.20.251983. Epub 2021 Mar 19.
To assess the implementation of a mobile dispensing service to improve opioid users' access to methadone maintenance therapy.
In March 2019, we started mobile methadone dispensing in an urban underprivileged locality in Delhi, India. The doctor was available only at the main community drug treatment clinic for clinical services, while the nurse dispensed methadone from a converted ambulance. We involved patients in identifying community leaders for sensitization and in deciding the location and timings for dispensing. We conducted a retrospective chart review of the programme data collected during delivery of clinical services. We compared the numbers of patients registered for methadone therapy and their retention and adherence to therapy in the 12-month periods before and after implementation of the mobile service.
The number of patients registered for therapy at the clinic increased from 167 in the year before implementation to 671 in the year after. A significantly higher proportion of patients were retained in therapy at 3, 6 and 9 months after enrolment; 9-month retention rates were 19% (32/167 patients) and 45% (44/97 patients) in the year before and after implementation, respectively. There was no significant difference in patients' adherence to therapy between the two periods. Challenges included providing suitable dispensing hours for patients in employment and concerns of local community near to the dispensing sites.
It is feasible to dispense methadone by a mobile team in an urban setting, with better retention rates in therapy compared with dispensing through a stationary clinic.
评估移动配药服务的实施情况,以改善阿片类药物使用者获得美沙酮维持治疗的机会。
2019 年 3 月,我们在印度德里一个城市贫困地区开始了移动美沙酮配药服务。医生仅在主要社区戒毒治疗诊所提供临床服务,而护士则从改装的救护车上分发美沙酮。我们让患者参与确定社区领导以进行宣传,并决定配药地点和时间。我们对在提供临床服务期间收集的项目数据进行了回顾性图表审查。我们比较了在实施移动服务前后 12 个月内登记接受美沙酮治疗的患者人数及其保留率和治疗依从性。
在实施移动服务之前,登记接受治疗的患者人数从 167 人增加到 671 人。在登记后 3、6 和 9 个月时,接受治疗的患者保留率显著提高;登记后 9 个月的保留率分别为 19%(32/167 例患者)和 45%(44/97 例患者),实施前后分别为 19%和 45%。两个时期患者治疗的依从性没有显著差异。面临的挑战包括为就业的患者提供合适的配药时间以及附近社区对配药点的担忧。
在城市环境中,通过移动小组配药是可行的,与通过固定诊所配药相比,治疗的保留率更高。